Literature DB >> 7555179

Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range.

J Hirsh, J E Dalen, D Deykin, L Poller, H Bussey.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 7555179     DOI: 10.1378/chest.108.4_supplement.231s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  29 in total

1.  Management of hemorrhagic events in patients receiving anticoagulant therapy.

Authors:  D G Love
Journal:  J Thromb Thrombolysis       Date:  1999-04       Impact factor: 2.300

2.  Community impact of anticoagulation services: rationale and design of the Managing Anticoagulation Services Trial (MAST).

Authors:  D B Matchar; G P Samsa; S J Cohen; E Z Oddone
Journal:  J Thromb Thrombolysis       Date:  2000-06       Impact factor: 2.300

Review 3.  Transient ischaemic attacks : new approaches to management.

Authors:  Ramesh Madhavan; Seemant Chaturvedi
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

4.  Compliance-guided therapy : a new insight into the potential role of clinical pharmacologists.

Authors:  Alexia Blesius; Sylvie Chabaud; Michel Cucherat; Patrick Mismetti; Jean-Pierre Boissel; Patrice Nony
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

5.  Should we just let the anticoagulation service do it? The conundrum of anticoagulation for atrial fibrillation.

Authors:  D B Matchar; G P Samsa; S J Cohen
Journal:  J Gen Intern Med       Date:  1996-12       Impact factor: 5.128

Review 6.  Superwarfarin (Long-Acting Anticoagulant Rodenticides) Poisoning: from Pathophysiology to Laboratory-Guided Clinical Management.

Authors:  Yeow-Kuan Chong; Tony Wing-Lai Mak
Journal:  Clin Biochem Rev       Date:  2019-11

Review 7.  Pregnancy After Cardiac Surgery.

Authors:  Anjali Vivek Kanhere; Vivek Madhav Kanhere
Journal:  J Obstet Gynaecol India       Date:  2016-02-08

8.  Warfarin in the secondary prevention of thromboembolism in atrial fibrillation: impact of bioavailability on costs and outcomes.

Authors:  Nicole Mittmann; Paul I Oh; Scott E Walker; William R Bartle
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 9.  Warfarin therapy: in need of improvement after all these years.

Authors:  Stephen E Kimmel
Journal:  Expert Opin Pharmacother       Date:  2008-04       Impact factor: 3.889

Review 10.  Pharmacogenetics of oral anticoagulants: a basis for dose individualization.

Authors:  Simone Stehle; Julia Kirchheiner; Andreas Lazar; Uwe Fuhr
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.